BenevolentAI

BenevolentAI is a company that applies advanced AI to accelerate biopharma drug discovery, helping researchers bring new treatments to patients faster in an industry where R&D is slow, costly, and full of uncertainty.

Its next-generation platform is built to target the complex decisions that drive R&D, providing life science intelligence that turns scattered data into clear, actionable insight for scientists and decision-makers.

The company builds technology in the service of science, bringing together dedicated science and technology teams to push AI and machine learning to new limits in support of real research goals.

By leveraging its knowledge graph and proprietary ontologies, BenevolentAI supports scientists and executives in using cutting-edge AI with confidence and precision, so critical decisions rest on a deeper understanding of the underlying biology.